We report on innovations in artificial intelligence and explore how businesses can take advantage of machine learning, robotics, task automation, and other AI technologies.
Real-world evidence (RWE) has become a crucial driver of the pharmaceutical and biotechnology industries in recent years. In fact, RWE is now included in 70 percent of new drug and biologic regulatory ...